Globus Medical to Acquire Nevro Corp. to Expand Treatment …
AUDUBON, Pa. and REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) - Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced they have entered into a definitive agreement for Globus Medical to acquire all ...
Globus Medical to Acquire Nevro Corp. to Expand Treatment …
5 days ago · Globus Medical and Nevro Preliminary Full-Year 2024 Revenue Outlook: On January 8, 2025, Globus Medical announced preliminary 2024 net sales of $2.52 billion, an increase of 60.6% over prior year ...
Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain?
Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement ...
Globus Medical to Acquire Nevro in $250 Million Deal to Expand …
5 days ago · Globus will buy all outstanding Nevro shares for $5.85 per share under the terms of the agreement, therefore reflecting a 27% premium over its 90-day volume-weighted average price and a 17% ...
Globus Medical to Acquire Nevro Corp. in All-Cash Transaction
5 days ago · Globus Medical and Nevro Preliminary Full-Year 2024 Revenue Outlook: On January 8, 2025, Globus Medical announced preliminary 2024 net sales of $2.52 billion, an increase of 60.6% over prior year ...
Globus Medical to Acquire Nevro Corp. to Expand Treatment
5 days ago · Globus Medical and Nevro Preliminary Full-Year 2024 Revenue Outlook: On January 8, 2025, Globus Medical announced preliminary 2024 net sales of $2.52 billion, an increase of 60.6% over prior year ...
Globus Medical to buy neurostim developer Nevro for $250M
1 day ago · Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its neuromodulation platforms for treating chronic pain. The all-cash deal comes ...
Globus to buy Nevro for $250M - MedTech Dive
6 days ago · Globus Medical plans to buy spinal cord stimulation company Nevro for about $250 million, the companies announced on Thursday. Globus will pay $5.85 per share in an all-cash purchase, a 27% premium to Nevro’s 90-day volume-weighted average price. ... Brandon Vazquez wrote in a research note that the price is a “relatively inexpensive ...
Globus Medical strengthens SCS market position with $250m Nevro …
2 days ago · Globus Medical, which has a market cap of $11.9bn, will buy all shares in Nevro for $5.85 each. Image credit: Shutterstock / Piotr Swat. Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...
Globus Medical to acquire Nevro for $5.85 per share
5 days ago · Globus Medical and Nevro Corp. have entered into a definitive agreement for Globus Medical to acquire all shares of Nevro in an all-cash transaction. Under the terms of the agreement,...
- Some results have been removed